Foto del docente

Lisa Argnani

Ricercatrice a tempo determinato tipo b) (senior)

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: MEDS-24/A Statistica medica

Pubblicazioni

Giladi, Odil; Bagnato, Gianmarco; Gentilini, Marianna; Shimony, Shai; Pasvolsky, Oren; Berger, Tamar; Itchaki, Gilad; Raanani, Pia; Lolli, Ginerva; Stefoni, Vittorio; Broccoli, Alessandro; Argnani, Lisa; Zinzani, Pier Luigi; Gurion, Ronit, Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study, «ANNALS OF HEMATOLOGY», 2024, 103, pp. 803 - 811 [articolo]

Di Staso, Rossana; Casadei, Beatrice; Gentilini, Marianna; Guadagnuolo, Serafina; Pellegrini, Cinzia; Broccoli, Alessandro; Gori, Davide; Masetti, Riccardo; Stefoni, Vittorio; Bonifazi, Francesca; Zinzani, Pier Luigi; Argnani, Lisa, Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity, «ANNALS OF HEMATOLOGY», 2024, 0, pp. 0 - 0 [articolo]Open Access

Casadei, Beatrice; Conti, Gabriele; Barone, Monica; Turroni, Silvia; Guadagnuolo, Serafina; Broccoli, Alessandro; Brigidi, Patrizia; Argnani, Lisa; Zinzani, Pier Luigi, Role of gut microbiome in the outcome of lymphoma patients treated with checkpoint inhibitors-The MicroLinf Study, «HEMATOLOGICAL ONCOLOGY», 2024, 42, Article number: e3301, pp. 1 - 12 [articolo]Open Access

Bagnato, Gianmarco; Stefoni, Vittorio; Broccoli, Alessandro; Argnani, Lisa; Pellegrini, Cinzia; Casadei, Beatrice; Bonifazi, Francesca; Zinzani, Pier Luigi, Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients, «MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES», 2024, 16, Article number: e2024004, pp. 1 - 4 [articolo]Open Access

Broccoli, Alessandro; Argnani, Lisa; Gugliotta, Gabriele; Pellegrini, Cinzia; Casadei, Beatrice; Bagnato, Gianmarco; Gentilini, Marianna; Stefoni, Vittorio; Zinzani, Pier Luigi, The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous Transplantation, «THE ONCOLOGIST», 2024, -, pp. 1 - 7 [articolo]Open Access

Gentilini, Marianna; Casadei, Beatrice; Morigi, Alice; Lolli, Ginevra; Ferrari, Marco; Carella, Matteo; Argnani, Lisa; Zinzani, Pier Luigi, Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case Report, «CHEMOTHERAPY», 2023, 68, pp. 219 - 221 [articolo]

Lolli, Ginevra; Argnani, Lisa; Gini, Guido; Casadei, Beatrice; Pellegrini, Cinzia; Tani, Monica; Pavone, Vincenzo; Cimminiello, Michele; Bonifazi, Francesca; Zinzani, Pier Luigi, Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T‐cell pathway in patients with diffuse large B‐cell lymphoma, «HEMATOLOGICAL ONCOLOGY», 2023, 41, pp. 947 - 950 [articolo]

Zoli, Sabrina; Pellegrini, Cinzia; Casadei, Beatrice; Broccoli, Alessandro; Argnani, Lisa; Nanni, Laura; Stefoni, Vittorio; Zinzani, Pier Luigi, Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-cell Lymphoma, Leg-type: A Case Report, «CHEMOTHERAPY», 2023, 1, pp. 23 - 26 [articolo]Open Access

Broccoli, Alessandro; Argnani, Lisa; Nanni, Laura; Stefoni, Vittorio; Pellegrini, Cinzia; Casadei, Beatrice; Gugliotta, Gabriele; Carella, Matteo; Coppola, Paolo Elia; Bagnato, Gianmarco; Zinzani, Pier Luigi, Single-agent rituximab is an effective salvage therapy in pretreated patients with hairy cell leukemia, «BLOOD ADVANCES», 2023, 7, pp. 6762 - 6766 [articolo]Open Access

Broccoli, Alessandro; Argnani, Lisa; Cross, Matthew; Janus, Agnieszka; Maitre, Elsa; Troussard, Xavier; Robak, Tadeusz; Dearden, Claire; Else, Monica; Catovsky, Daniel; Zinzani, Pier Luigi, A 3-decade multicenter European experience with cladribine as upfront treatment in 384 hairy cell leukemia patients, «BLOOD ADVANCES», 2022, 6, pp. 4224 - 3 [articolo]Open Access

Giladi O.; Bagnato G.; Gentilini M.; Shimony S.; Pasvolsky O.; Berger T.; Itchaki G.; Raanani P.; Broccoli A.; Stefoni V.S.; Lolli G.; Argnani L.; Zinzani P.L.; Gurion R., ABCL-298 Diffuse Large B-Cell Lymphoma During the Covid-19 Pandemic in Two Tertiary Centers: The Israeli/Italian Study, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2022, 22, pp. 370 - 371 [articolo]

Lolli, Ginevra; Ursi, Margherita; Dicataldo, Michele; Casadei, Beatrice; Storci, Gianluca; Argnani, Lisa; Bonifazi, Francesca; Zinzani, Pier Luigi, Allogeneic stem cell transplantation is capable of healing a case of bone marrow aplasia following CAR-T cell therapy in a lymphoma patient, «LEUKEMIA & LYMPHOMA», 2022, Epub ahead of print, pp. 1 - 3 [articolo]

Alderuccio, Juan Pablo; Arcaini, Luca; Watkins, Marcus P; Beaven, Anne W; Shouse, Geoffrey; Epperla, Narendranath; Spina, Michele; Stefanovic, Alexandra; Sandoval-Sus, Jose; Torka, Pallawi; Alpert, Ash B; Olszewski, Adam J; Kim, Seo-Hyun; Hess, Brian; Gaballa, Sameh; Ayyappan, Sabarish; Castillo, Jorge J; Argnani, Lisa; Voorhees, Timothy J; Saba, Raya; Chowdhury, Sayan Mullick; Vargas, Fernando; Reis, Isildinha M; Kwon, Deukwoo; Alexander, Jonathan S; Zhao, Wei; Edwards, Dali; Martin, Peter; Cencini, Emanuele; Kamdar, Manali; Link, Brian K; Logothetis, Constantine N; Herrera, Alex F; Friedberg, Jonathan W; Kahl, Brad S; Luminari, Stefano; Zinzani, Pier Luigi; Lossos, Izidore S, An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma, «BLOOD ADVANCES», 2022, 6, pp. 2035 - 2044 [articolo]Open Access

Stefoni V.; Argnani L.; Carella M.; Casadei B.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Coppola P.E.; Zinzani P.L., BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience, «JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY», 2022, Online ahead of print, pp. 1 - 5 [articolo]Open Access

Stefoni V.; Pellegrini C.; Argnani L.; Corradini P.; Dodero A.; Orsucci L.; Volpetti S.; Zinzani P.L., Brentuximab vedotin in the treatment of relapsed/refractory CD30+ peripheral T-cell lymphoma: A FIL phase 2 study, «HEMATOLOGICAL ONCOLOGY», 2022, 40, pp. 307 - 309 [articolo]